X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Cipla Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cipla Quarterly Results   (CIPL)

Here are the latest quarterly results of Cipla. For more details, see the Cipla financial fact sheet and Cipla share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Cipla Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m34,52431,06632,66535,93737,51036,47235,82035,251 
Other income Rs m2597935472522721,5352281,514 
Turnover Rs m34,78331,85933,21336,18937,78338,00736,04836,764 
Expenses Rs m26,63026,52830,47629,82830,70329,69630,75828,786 
Gross profit Rs m7,7084,3632,0046,0306,6346,6675,0536,465 
Depreciation Rs m1,3401,3751,4141,6082,2922,5776,3222,134 
Interest Rs m503230367313352593334279 
Profit before tax Rs m6,1253,5527704,3614,2625,031-1,3755,566 
Tax Rs m1,812120-397087191,283-7571,308 
Profit after tax Rs m4,3123,4328093,6523,5433,748-6184,258 
Gross profit margin %22.314.06.116.817.718.314.118.3 
Effective tax rate %29.63.4-5.116.216.925.555.123.5 
Net profit margin %12.511.02.510.29.410.3-1.712.1 
Diluted EPS Rs 5.4 4.3 1.0 4.5 4.4 4.7 -0.8 5.3  
Diluted EPS (TTM) Rs 20.8 20.9 18.7 15.2 14.2 14.6 12.8 13.6  
 Subscriber Feature   View View View   View      
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   BIOCON LTD  ALKEM LABORATORIES  TORRENT PHARMA  ELDER PHARMA  ALEMBIC PHARMA  

Compare CIPLA With:   BIOCON LTD  ALKEM LABORATORIES  TORRENT PHARMA  ELDER PHARMA  ALEMBIC PHARMA  

Compare CIPLA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Open Flat; Yes Bank Top Gainer(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.31% while the Hang Seng is up 0.07%. The Shanghai Composite is trading up by 0.35%.

Views on news

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Jan 19, 2018 11:19 AM

TRACK CIPLA

COMPARE CIPLA WITH

MARKET STATS